Lanoxin - Digoxin
4 customer reviewsLanoxin is an oral digoxin tablet for adults with heart failure or certain supraventricular arrhythmias such as atrial fibrillation. It helps the heart contract more strongly and slows AV-node conduction to control ventricular rate.
What is it?
Lanoxin is an oral tablet medicine containing digoxin, a cardiac glycoside used in adults with heart failure and certain supraventricular arrhythmias such as atrial fibrillation. It is chosen when improving the strength of heart contractions and controlling ventricular rate are key goals. Digoxin works by increasing intracellular calcium in heart muscle and slowing electrical conduction through the AV node, which can improve symptoms and stabilise rhythm.
Lanoxin has a narrow therapeutic window. Small dose changes, kidney function, and electrolyte shifts can move treatment from helpful to toxic, so monitoring is part of using it well. [1]
Digoxin is also used as an antiarrhythmic agent in the sense that it can help control heart rate in supraventricular arrhythmias, mainly by acting at the atrioventricular node. You may see it grouped under ANTIARRHYTHMICS in clinical references and hospital formularies. One sentence that matters: it is a medicine where dosing precision is the whole point.
Composition
Lanoxin is an oral tablet medicine containing digoxin. On this page, Lanoxin is supplied as tablets. The tablet strength available here is 0.25 mg digoxin.
How to use?
On this page, Lanoxin is supplied as tablets. The tablet strength available here is 0.25 mg digoxin.
Lanoxin dosing is not “one size fits all”. Clinicians often choose a strength based on kidney function, age, body size, and the treatment target (rate control vs symptom relief in heart failure).
A practical way clinicians think about dosing:
- Loading dose (PO): used when faster effect is needed; selection is based on clinical response and toxicity risk.
- Maintenance dose (PO): a daily dose; selection is based on clinical response, kidney function, age, and interacting medicines.
Three small rules help a lot.
Take it at the same time daily.
Swallow with water.
Missed dose approach used in practice: take it when remembered unless the next dose is close, then skip and continue on schedule. Double-dosing is a common route to toxicity, especially in older adults with reduced renal clearance.
How does it work?
- Oral tablets: Take 0.125–0.25 mg by mouth once daily.
- Timing: Take the tablet at the same time each day, with or without food; if nausea occurs, take it after meals.
- Duration: Use daily for long-term treatment as prescribed; do not stop or change the dose on your own.
- Route: Oral only.
Indications
Lanoxin tablets are used for two core clinical goals: support cardiac pumping in heart failure and control heart rate in certain supraventricular arrhythmias.
Typical uses include:
- Heart failure: to improve symptoms such as fatigue and shortness of breath by helping the heart contract more effectively.
- Atrial fibrillation: to slow AV-node conduction and reduce a fast ventricular response.
- Atrial flutter: to help control ventricular rate in selected patients.
- Other supraventricular arrhythmias: where AV-node slowing is clinically useful.
Atrial fibrillation and atrial flutter originate in the upper chambers (atria). Lanoxin does not “reset” the rhythm by itself; it mainly helps keep the ventricular rate under control so the heart works more efficiently.
Comparison
Lanoxin sits in a specific niche: helpful for symptom relief in heart failure and for ventricular rate control in atrial fibrillation, with close attention to dosing and interactions.
| Option | How it compares | Typical place in therapy |
|---|---|---|
| Lanoxin (digoxin) | Increases contractility and slows AV-node conduction | Heart failure symptoms plus AF rate control in selected patients |
| Beta-blockers | Strong rate control; no inotropic boost; may lower blood pressure | Often first-line for AF rate control; core therapy in many HF regimens |
| Non-dihydropyridine calcium channel blockers | Rate control via AV node; can reduce contractility | AF rate control in patients without certain HF profiles |
Lanoxin’s advantage is the combination of contractility support plus AV-node slowing. The trade-off is a narrow therapeutic window and more interaction management than many alternatives.
Contraindications
- Known allergy to digoxin or other cardiac glycosides
- Second- or third-degree AV block or sick sinus syndrome unless a pacemaker is in place
- Wolff-Parkinson-White syndrome with atrial fibrillation
- Acute myocardial infarction in settings where digoxin is not appropriate for the rhythm/haemodynamic profile
Not recommended for
This medication is not a good fit if you have a digoxin allergy, certain heart block problems, or a rhythm disorder such as WPW with atrial fibrillation. It also needs extra caution if your kidneys are weak or your potassium or magnesium tends to run low.
Side effects
Side effects from Lanoxin range from mild to urgent. Many early symptoms overlap with toxicity, which is why clinicians take new symptoms seriously.
Commonly reported effects include:
- Nausea, vomiting, diarrhoea
- Dizziness, weakness, tiredness
- Visual disturbances such as blurred vision or yellow/green tinting (xanthopsia)
One-sentence red flag: new visual changes on digoxin deserve prompt clinical review. Digoxin references used by the EMA list gastrointestinal and visual symptoms as classic early signals when levels run high. [3]
Less common effects can include headache, rash, and breast enlargement in men (gynecomastia). Dangerous reactions include significant bradycardia, heart block, and ventricular arrhythmias—these require urgent assessment.
Human micro-detail from real-world counselling: people often describe the vision change as “a weird yellow cast” rather than blurry vision, and it can come with loss of appetite before vomiting starts.
Common mistakes
People rarely “forget” digoxin in dramatic ways. The common issues are small and repetitive.
- Doubling up after a missed dose. This is a top trigger for nausea and slow pulse a day later.
- Starting an interacting medicine without flagging digoxin. Antibiotics and antiarrhythmics are classic culprits, and the interaction can show up as appetite loss first.
- Ignoring dehydration. Diarrhoea, vomiting, or fasting can drop potassium and magnesium, and digoxin becomes less forgiving.
- Treating visual symptoms as an eye problem. Yellow/green halos can be drug-related, not “ageing eyes”.
- Assuming a stable dose means stable levels forever. A change in kidney function can shift serum digoxin levels without warning.
One more insider detail: some patients chase a “perfect” resting heart rate with extra doses. Rate control targets differ person to person, and self-adjustment is where toxicity stories start.
Doctor opinions
In clinical practice, cardiologists and internal medicine doctors often keep digoxin for specific patient profiles: atrial fibrillation with heart failure symptoms where rate control is needed, or persistent symptoms despite other heart failure medicines. It is not a “more is better” drug; prescribers aim for the lowest dose that controls symptoms and rate.
Frequently asked questions
Lanoxin can start affecting heart rate within hours, while symptom changes in heart failure may take days to a few weeks depending on the clinical situation and background therapy. The timing also depends on whether a loading dose was used or whether the dose was started low and adjusted slowly. Clinical pharmacology references used by the EMA describe both rapid electrophysiologic effects and slower symptom response patterns.
A missed dose is usually taken when remembered unless the next scheduled dose is close, in which case it is skipped and the regular schedule continues. Double dosing raises the risk of bradycardia, nausea, and rhythm disturbances. People with kidney impairment are more sensitive to dose stacking because digoxin clearance is slower.
Monitoring often includes pulse/rhythm assessment, kidney function tests, electrolytes (potassium and magnesium), and sometimes serum digoxin levels. Serum digoxin levels are most useful when interpreted with timing, symptoms, kidney function, and interacting medicines. A “normal number” does not always match how a patient feels, so clinicians treat the full picture.
Lanoxin does not directly “consume” potassium, yet low potassium makes the heart more sensitive to digoxin and increases toxicity risk. Diuretics, diarrhoea, vomiting, and poor intake are common reasons potassium drops. Clinicians often correct electrolytes first if side effects appear early after starting digoxin.
IV digoxin is a hospital route used in selected situations when oral dosing is not suitable or rapid effect is needed. Clinical protocols often avoid IV digoxin in patients who have already received other cardiac glycosides recently, because stacked glycoside exposure increases toxicity risk. For home therapy, Lanoxin on this page is taken orally as tablets.
Pregnancy and lactation decisions depend on the mother’s rhythm problem and heart function, plus monitoring capacity. Digoxin can cross the placenta and can enter breast milk, so clinicians aim for stable dosing and careful assessment of symptoms and labs. The key clinical goal is maternal cardiovascular stability, since uncontrolled arrhythmia or decompensated heart failure carries risk to both mother and baby.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Lanoxin — Comparison with alternatives
Lanoxin Current Best price
Pradaxa
Entresto
Trental Best rated
Prasugrel
Reviews and Experiences
Sources
- U.S. Food and Drug Administration (FDA) (2016). DIGOXIN tablets — prescribing information (label) ↑
- World Health Organization (WHO) (2023). WHO Model Formulary 2023: Digoxin monograph ↑
- European Medicines Agency (EMA) (2023). Digoxin SmPC ↑
- MOHAP (Ministry of Health and Prevention) (2024). Medication safety guidance on maintaining an updated medicine list ↑
- European Medicines Agency (EMA) (2023). Digoxin SmPC: pregnancy and lactation section ↑